Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis

MLA

Malin Hultcrantz, et al. “Comparison of Venous Thromboembolism Incidence in Newly Diagnosed Multiple Myeloma Patients Receiving Bortezomib, Lenalidomide, Dexamethasone (RVD) or Carfilzomib, Lenalidomide, Dexamethasone (KRD) with Aspirin or Rivaroxaban Thromboprophylaxis.” British Journal of Haematology, vol. 196, Aug. 2021, pp. 105–09. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f97ba277ff5b04d9bed5725906da312a&authtype=sso&custid=ns315887.

APA

Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Sydney Lu, Dhwani Patel, Tim J Peterson, Neha Korde, Carlyn Tan, Katrina M Piedra, Urvi A Shah, Alexander M. Lesokhin, Jennifer S. Orozco, Andriy Derkach, & Cy Wilkins. (2021). Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxis. British Journal of Haematology, 196, 105–109.

Chicago

Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Sydney Lu, Dhwani Patel, Tim J Peterson, Neha Korde, et al. 2021. “Comparison of Venous Thromboembolism Incidence in Newly Diagnosed Multiple Myeloma Patients Receiving Bortezomib, Lenalidomide, Dexamethasone (RVD) or Carfilzomib, Lenalidomide, Dexamethasone (KRD) with Aspirin or Rivaroxaban Thromboprophylaxis.” British Journal of Haematology 196 (August): 105–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f97ba277ff5b04d9bed5725906da312a&authtype=sso&custid=ns315887.